SKL27969

· SK Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SKL27969, covering 2025-05-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients [Phase 1, Phase 2]

See pricing